| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(14)70940-5 |
| P698 | PubMed publication ID | 25303843 |
| P50 | author | Kathleen Kahn | Q60500113 |
| Umesh Parashar | Q61190129 | ||
| Sibongile Walaza | Q61196380 | ||
| Margaret M Cortese | Q89695802 | ||
| Meera Chhagan | Q92620576 | ||
| Elizabeth Zell | Q106358676 | ||
| Jocelyn Moyes | Q114401271 | ||
| Constant N Kapongo | Q114432752 | ||
| Christine Mulligan | Q114432753 | ||
| Mapaseka Seheri | Q114432755 | ||
| Nicola Page | Q40130360 | ||
| Michelle J. Groome | Q40130392 | ||
| Heather Zar | Q42212160 | ||
| Cheryl Cohen | Q55762440 | ||
| Shabir A. Madhi | Q56065756 | ||
| P2093 | author name string | Jessica A Fleming | |
| Jeffrey Mphahlele | |||
| A Duncan Steele | |||
| Ralph Diedericks | |||
| P2860 | cites work | Rotavirus vaccines: current status and future considerations | Q27021385 |
| Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis | Q56995254 | ||
| Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants | Q57530944 | ||
| Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil | Q57530949 | ||
| Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study | Q79958029 | ||
| Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study | Q33915516 | ||
| Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants | Q33988269 | ||
| 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis | Q34227701 | ||
| Duration of protection of pentavalent rotavirus vaccination in Nicaragua | Q34285523 | ||
| Eliminating mother-to-child HIV transmission in South Africa | Q36509402 | ||
| HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life | Q36727938 | ||
| Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study | Q36942818 | ||
| Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? | Q38022320 | ||
| Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial | Q38879736 | ||
| Burden and Epidemiology of Rotavirus Diarrhea in Selected African Countries: Preliminary Results from the African Rotavirus Surveillance Network | Q39285962 | ||
| Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial | Q39944921 | ||
| Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization Following Introduction into the South African Public Immunization Program | Q40130267 | ||
| Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine | Q40489497 | ||
| Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa | Q40610166 | ||
| Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials | Q42615115 | ||
| Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period | Q44284848 | ||
| Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study | Q44881283 | ||
| Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa. | Q45373052 | ||
| Child mortality according to maternal and infant HIV status in Zimbabwe | Q46339318 | ||
| Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. | Q46390356 | ||
| Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme. | Q46611060 | ||
| The case test-negative design for studies of the effectiveness of influenza vaccine | Q51225150 | ||
| P433 | issue | 11 | |
| P921 | main subject | South Africa | Q258 |
| diarrhea | Q40878 | ||
| rotavirus vaccine | Q4411598 | ||
| P304 | page(s) | 1096-1104 | |
| P577 | publication date | 2014-10-07 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study | |
| P478 | volume | 14 |
| Q38408691 | A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia |
| Q54674897 | Can Changes to Scheduling Enhance the Performance of Rotavirus Vaccines in Low-Income Countries? |
| Q37563622 | Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries |
| Q31072142 | Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data |
| Q47291480 | Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors |
| Q52588289 | Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania. |
| Q58605774 | Diarrheal etiology and impact of co-infections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India |
| Q36388856 | Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium? |
| Q59134865 | Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction |
| Q90147313 | Diversity of Rotavirus Strains Circulating in Botswana before and after introduction of the Monovalent Rotavirus Vaccine |
| Q40045569 | Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis |
| Q40722616 | Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study |
| Q36356363 | Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016. |
| Q33574342 | Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial |
| Q35217987 | Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study |
| Q37375983 | Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status |
| Q59810627 | Effectiveness of the Oral Human Attenuated Rotavirus Vaccine: A Systematic Review and Meta-analysis-2006-2016 |
| Q46242046 | Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia |
| Q39898038 | Epidemiology of rotavirus A diarrhea in Chókwè, Southern Mozambique, from February to September, 2011. |
| Q36076150 | Etiologies, Risk Factors and Impact of Severe Diarrhea in the Under-Fives in Moramanga and Antananarivo, Madagascar |
| Q92267944 | Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa |
| Q49492887 | Evaluation of the Influence of Gastrointestinal Coinfections on Rotavirus Vaccine Effectiveness in Botswana |
| Q64130682 | Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? |
| Q90205167 | Genetic characterization of group-A rotaviruses among children in eastern India during 2014-2016: Phylodynamics of co-circulating genotypes |
| Q30062047 | HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. |
| Q38534245 | Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa |
| Q40722580 | Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana |
| Q59383929 | Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study |
| Q38638982 | Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children |
| Q57297216 | Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5 years of age with gastroenteritis in Ethiopia: 2011-2016 |
| Q30252225 | Impact of rotavirus vaccine introduction and post-introduction etiology of diarrhea requiring hospital admission in Haydom, Tanzania, a rural African setting |
| Q47433785 | Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar |
| Q41928438 | Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar |
| Q64137346 | Impact of rotavirus vaccines in Sub-Saharan African countries |
| Q64137793 | Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda |
| Q91809009 | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
| Q90207859 | Measuring Rotavirus Vaccine Impact in sub-Saharan Africa |
| Q90191792 | Mixed Aetiology of Diarrhoea in Infants Attending Clinics in the North-West Province of South Africa: Potential for Sub-Optimal Treatment |
| Q31141017 | Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction |
| Q36871954 | Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial |
| Q38844845 | Norovirus epidemiology in South African children <5 years hospitalised for diarrhoeal illness between 2009 and 2013. |
| Q36781547 | Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses |
| Q35999759 | Population-Based Incidence Rates of Diarrheal Disease Associated with Norovirus, Sapovirus, and Astrovirus in Kenya |
| Q47422430 | Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality |
| Q40693674 | Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines |
| Q60910627 | Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013 |
| Q98625964 | Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis |
| Q37175410 | Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis |
| Q64130062 | Reduction of hospitalizations with diarrhea among children aged 0-5 years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine |
| Q41589121 | Rotavirus Vaccines: a story of success with challenges ahead |
| Q44511103 | Rotavirus landscape in Africa-Towards prevention and control: A report of the 8th African rotavirus symposium, Livingstone, Zambia |
| Q49685260 | Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introduction |
| Q47569749 | Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction |
| Q37375904 | Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries |
| Q37499028 | Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design |
| Q41511734 | Rotavirus vaccines roll-out in resource-deprived regions |
| Q59360403 | Rotavirus vaccines: why continued investment in research is necessary |
| Q40529372 | Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa |
| Q40943313 | Success of rotavirus vaccination in Africa: good news and remaining questions |
| Q41706230 | Sustaining rotavirus vaccination in Africa: Measuring vaccine effectiveness |
| Q40722593 | Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa |
| Q47588528 | Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014. |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q92639992 | The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines |
| Q39063800 | The economic impact of childhood acute gastroenteritis on Malawian families and the healthcare system |
| Q47712166 | The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. |
| Q88486650 | The influence of incomplete case ascertainment on measures of vaccine efficacy |
| Q40722670 | Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies |
| Q63683024 | Vaccination among HIV–infected, HIV-exposed uninfected and HIV-uninfected children: A systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness |
| Q30248486 | Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies |
| Q64117280 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
| Q59356442 | Viral gastroenteritis |
| Q59360740 | Whole-genome sequencing and analyses identify high genetic heterogeneity, diversity and endemicity of rotavirus genotype P[6] strains circulating in Africa |
| Q38597203 | Zoonotic transmission of rotavirus: surveillance and control |
Search more.